Spanish Biotech Integra Therapeutics Secures Licensing Deal with Caszyme to Boost Gene Editing Capabilities
Spanish biotech firm Integra Therapeutics has announced a strategic agreement to enhance its gene editing capabilities by licensing Cas12I nucleases ...